Skip to main content

Bio Essence Corp

corporate_fare Company Profile

Bio Essence Corp

BIOE·OTC·Life Sciences·CIK 0001723059

Bio Essence Corp. is an herbal health, diet, and nutrition company that provides herbal health, diet, and vitamin nutritional supplements. The Company was incorporated in California on January 1, 2000. On January 27, 2016, Jian Yang purchased a controlling interest in the Company and entered into a stock purchase agreement with Fusion Diet Systems, Inc. dba Fusion Naturals, a Utah corporation incorporated on April 20, 2010. On January 9, 2017, the Company created Bio Essence Pharmaceutical, Inc. ("BEP") in California to serve as a health supplements manufacturer. On January 12, 2017, the Company created its third subsidiary, Bio Essence Herbal Essentials Inc. ("BEH"). The Company served as a holding corporation for these subsidiaries. On November 13, 2021, the Company dissolved Fusion Naturals and formed McBE Pharma, Inc. ("McBE") as a new wholly owned subsidiary. BEP's primary focus was producing products for BEH and McBE, and providing original equipment manufacturing (OEM) and private label services to other companies. BEH targeted and developed traditional Chinese medicines ("TCM") as single herbs, granules, pills, and tablets, and offered special formulated dietary supplements and medical food. On December 12, 2023, the Company sold 100% equity ownership of BEP to Newway Inc for $300,000. On March 28, 2024, the Company agreed to sell 100% equity ownership of BEH to Health Up Inc. for $400,000. On April 15, 2024, the Company dissolved McBE. The Company now manages its operations directly, selling healthy supplement products and providing OEM services.

Bio Essence Corp (OTC:BIOE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for BIOE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for BIOE spans 10-Q, PRE 14C, 8-K/A, 8-K.

Recent high-impact activity:

  • Bio Essence Q3 Swings to $150K Loss; Going Concern and Weak Controls Reaffirmed
  • Bio Essence Creates 10,000-Vote Preferred Class via Written Consent
  • Bio Essence Q2 Revenue Jumps 207% but Going Concern and Control Weaknesses Persist
  • Bio Essence Finalizes MediFlow AI Acquisition, Issues 7M Shares at $0.50
  • Q1 Profit Turnaround Amidst Going Concern, Dilutive Offerings, and Control Weaknesses

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.9M
Net Income
$896.2K
Op. Cash Flow
$1.57M
Gross Profit
$1.43M
Operating Income
$900.01K
Debt / Equity
0.00×
Net Margin
47.2%
Shares Outstanding
38.01M sh
Source: 10-K · filed 2026-03-27 · accession 0001213900-26-035467

Short Interest & Short Volume

2.11 days to cover

FINRA reported short interest of 7,738 shares in BIOE as of the October 30, 2026 settlement, a 2067.5% increase from the prior period — about 2.1 days to cover at its recent average daily volume.

Short interest (bi-monthly positions)7,738 shares as of October 30, 2026
Change vs prior period▲ 2067.5%
Days to cover2.11 at avg daily volume of 3,671

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$0.47
52-week range · as of 2026-11-13 $0.051 – $10.81
Market cap
$25.29M
Volume
5.5K (0.5× avg)
3-mo avg 11K
Live data · 2026-11-21 12:32 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BIOE - Latest Insights

BIOE
Nov 12, 2026, 8:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.470
Real-time Price: $0.470 info
Change: $0 (0%) info
Market Cap: $25.29M info
BIOE
Oct 21, 2026, 10:41 AM EDT
Filing Type: PRE 14C
Importance Score:
7
Price at Filing: $0.4201
Real-time Price: $0.470 info
Change: +$0.0499 (+12%) info
Market Cap: $25.29M info
BIOE
Aug 14, 2026, 4:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.250
Real-time Price: $0.470 info
Change: +$0.220 (+88%) info
Market Cap: $25.29M info
BIOE
May 19, 2026, 4:01 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $0.300
Real-time Price: $0.470 info
Change: +$0.170 (+57%) info
Market Cap: $25.29M info
BIOE
May 15, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.380
Real-time Price: $0.470 info
Change: +$0.090 (+24%) info
Market Cap: $25.29M info
BIOE
Apr 23, 2026, 8:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.450
Real-time Price: $0.470 info
Change: +$0.020 (+4%) info
Market Cap: $25.29M info
BIOE
Mar 27, 2026, 3:44 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.170
Real-time Price: $0.470 info
Change: +$0.300 (+176%) info
Market Cap: $25.29M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets